No results for ‘’
Bayer CropScience Ltd
₹4327.10
(0.27%)
Mon, 25 May 2026, 09:44 am
Process Industries
Chemicals: Agricultural
24.5KBayer CropScience Debt to Equity Ratio
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 24.83 | 18.85 | 24.94 | 10.43 | 20.18 | 27.53 | 22.80 | 4.10 | 20.06 | 31.80 | 43.15 | 46.09 | 48.78 | 55.88 | 32.76 | 48.36 | 34.70 | 23.99 | 31.82 | 38.99 |
| Price to book ratio | 3.29 | 3.13 | 2.48 | 2.18 | 4.59 | 5.38 | 4 | 2.46 | 3.17 | 5.99 | 7.24 | 6.52 | 8.11 | 6.72 | 6.04 | 9.35 | 8.87 | 6.71 | 8.27 | 7.77 |
| Price to sales ratio | 1.45 | 1.45 | 1 | 0.72 | 1.58 | 1.78 | 1.44 | 1.81 | 1.88 | 3.43 | 4.91 | 4.79 | 5.40 | 5.95 | 4.31 | 5.60 | 4.73 | 3.54 | 4.62 | 4.05 |
| Price to cash flow ratio | 0 | 34.03 | 6.60 | 37.65 | 35.97 | 30.53 | 25.75 | 26.04 | 16.15 | 46.29 | 52.03 | 65.18 | 102.59 | 41.30 | 22.39 | 33.45 | 96.81 | 29.19 | 24.19 | 73.77 |
| Enterprise value | 10.41B | 11.29B | 9.56B | 10.09B | 26.67B | 34.53B | 27.4B | 37.85B | 53.14B | 110.21B | 127.96B | 125.25B | 142.22B | 182.56B | 144.78B | 226.09B | 216.53B | 173.57B | 223.93B | 213.21B |
| Enterprise value to EBITDA ratio | 6.82 | 18.94 | 51.78 | 11.73 | 19.57 | 12.71 | 8.03 | 8.85 | 16.22 | 26.17 | 28.58 | 29.23 | 33.66 | 36.14 | 19.71 | 27.51 | 26.04 | 18.33 | 22.44 | 29.82 |
| Debt to equity ratio | 0.42 | 0.34 | 0.19 | 0.09 | 0.20 | 0.16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0.01 | 0.03 | 0.03 | 0.02 | 0.04 |
| Return on equity % | 13.93 | 17.78 | 10.45 | 23.03 | 25.18 | 21.34 | 18.97 | 85.29 | 15.76 | 20.29 | 16.27 | 15.27 | 15.65 | 16.78 | 21.30 | 19.25 | 25.43 | 28.96 | 26.63 | 19.93 |
Bayer CropScience Ltd Debt to Equity Ratio
The Bayer CropScience Ltd Debt to Equity Ratio is a key financial metric used by investors to evaluate Bayer CropScience Ltd's valuation, profitability, and overall financial performance. Tracking the Bayer CropScience Ltd Debt to Equity Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Bayer CropScience Ltd (NSE: BAYERCROP, BSE: 506285) is currently trading at ₹4327.10, with a market capitalization of ₹195.67B. As a leading company in the Process industries sector and Chemicals: agricultural industry, monitoring the Bayer CropScience Ltd Debt to Equity Ratio is essential for fundamental analysis.
Bayer CropScience Ltd Debt to Equity Ratio Current Value
The current Bayer CropScience Ltd Debt to Equity Ratio stands at 0.04.
The latest Bayer CropScience Ltd Debt to Equity Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Bayer CropScience Ltd Debt to Equity Ratio Historical Trend
The Bayer CropScience Ltd Debt to Equity Ratio has shown the following historical trend:
- 2024: 0.04
- 2023: 0.02
- 2022: 0.03
- 2021: 0.03
- 2020: 0.01
The recent rise in Bayer CropScience Ltd Debt to Equity Ratio suggests strengthening valuation trends and improving market sentiment.
What Bayer CropScience Ltd Debt to Equity Ratio Indicates for Investors
The Bayer CropScience Ltd Debt to Equity Ratio plays a crucial role in understanding the company's financial health and valuation.
The D/E ratio measures financial leverage and balance sheet strength.
Bayer CropScience Ltd Debt to Equity Ratio Analysis Summary
The Bayer CropScience Ltd Debt to Equity Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Bayer CropScience Ltd Debt to Equity Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Bayer CropScience Ltd Debt to Equity Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.